/Investor DB

Illumina Ventures — 2023 Investments

1 investments dated 2023 · listed companies and verified rows first · show all

Pattern Biosciencepattern.bioin𝕏Series B · Apr 2023 · $28.7M✓ verified

Pattern develops rapid antibiotic susceptibility and infection diagnostics using single-cell microbiology, which reads the metabolic patterns of individual bacterial cells to deliver ID/AST results in hours without culture steps.

BiotechHealthtechMedical DevicesAustin, US

Nick Arab(Founder & CTO)Ross Johnson(Co-founder & Chief Engineer)inCarey-Ann Burnham(Chief Executive Officer)inTravis Davies(SVP, Operations)inKyle Fieleke(SVP, Corporate Development & Finance)inDavid Bussian(SVP, Clinical, Regulatory & Assay Development)in

Co-investorsAMR Action FundIllumina Innovation

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.